Back to search
Refractory Cold Agglutinin Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cold Agglutinin Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cold Agglutinin Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To evaluate the efficacy and safety of ipecopam in the treatment of refractory/relapsed AIHA.
This multicenter, phase II, open label study will enroll patients with chronic cold agglutinin disorder. A single course of Bortezomib will be given at the dose…